BioNTech is a German biotechnology company focused on messenger RNA (mRNA) therapeutics and vaccines. It co-developed the widely used COVID-19 vaccine Comirnaty with Pfizer and continues to advance mRNA and immunotherapy programs, particularly in oncology. Research spans individualized cancer vaccines, infectious-disease candidates, and other precision medicines. The company combines proprietary mRNA platforms with clinical development partnerships for global reach.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 260.8 | — | -386.6 | — |
| Q3 2025 | 1,518.9 | — | -28.7 | — |
| Q4 2025 | 907.4 | — | -305 | — |
| Q1 2026 | 118.1 | — | -531.9 | — |
| Q2 2026 | 105.6 | -59.5% | -820.8 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: T. Rowe Price Group, Inc. (TROW), J.B. Hunt Transport Services, Inc. (JBHT), Viatris Inc. (VTRS), Guardant Health, Inc. (GH), Entegris, Inc. (ENTG), Insmed Incorporated (INSM)